We are looking for young people 2–17 years of age to join a clinical trial to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or Crohn’s disease (CD) (including associated symptoms such as diarrhea with blood and pus, stomach pain, diarrhea, weight loss and/or anemia), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrolling for a limited time.
